Application of microdialysis in tumor

Abstract

Zhou Jingchao, Li Juan, Liu Chunsheng, Zhou Dinghua, Tong Weihang, Wang Dan. Application of microdialysis in tumor[J]. Journal of International Oncology, 2014, 41(8): 570-573.

［1］ Jacobs S, McCully CL, Murphy RF, et al. Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates［J］. Cancer Chemother Pharmacol, 2010, 65(5): 817-824. ［2］ Dave N, Gudelsky GA, Desai PB. The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis［J］. Cancer Chemother Pharmacol, 2013, 72(2): 349-357. ［3］ Miyajima M, Kusuhara H, Takahashi K, et al. Investigation of the effect of active efflux at the bloodbrain barrier on the distribution of nonsteroidal aromatase inhibitors in the central nervous system［J］. J Pharm Sci, 2013, 102(9): 3309-3319. ［4］ Blakeley JO, Olson J, Grossman SA, et al. Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study［J］. J Neurooncol, 2009, 91(1): 51-58. ［5］ Villarroel MC, Pratz KW, Xu L, et al. Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients［J］. Invest New Drugs, 2012, 30(6): 2096-2102. ［6］ Martins FC, de Oliveira CF. Chemotherapy and the future: microdialysis as a local administration technique［J］. Eur J Gynaecol Oncol, 2009, 30(1): 5-8. ［7］ Martins FC, Santos JL, de Oliveira CF. Microdialysis: improving local chemotherapy in cancer using a mathematical model［J］. Front Biosci (Elite Ed), 2012, 4: 401-409. ［8］ Portnow J, Badie B, Chen M, et al. The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation［J］. Clin Cancer Res, 2009, 15(22): 7092-7098. ［9］ Konings IR, Sleijfer S, Mathijssen RH, et al. Increasing tumoral 5fluorouracil concentrations during a 5day continuous infusion: a microdialysis study［J］. Cancer Chemother Pharmacol, 2011, 67(5): 1055-1062. ［10］ Redman LM, Moro C, Dobak J, et al. Association of β2 adrenergic agonist and corticosteroid injection in the treatment of lipomas［J］. Diabetes Obes Metab, 2011, 13(6): 517-522. ［11］ Sani SN, Henry K, Bhlke M, et al. The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumorbearing mice: a microdialysis study［J］. Cancer Chemother Pharmacol, 2010, 66(1): 159-169. ［12］ Carcaboso AM, Elmeliegy MA, Shen J, et al. Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas［J］. Cancer Res, 2010, 70(11): 4499-4508. ［13］胡凌云, 李亚里. 乳腺癌的早期预警. 国际肿瘤学杂志, 2011, 38(2): 118-120. ［14］ Nilsson UW, Abrahamsson A, Dabrosin C. Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy redues breast cancer growth in vivo［J］. Clin Cancer Res, 2010, 16(14): 3659-3669. ［15］ Lindahl G, Saarinen N, Abrahamsson A, et al. Tamoxifen, flaxseed, and the lignan enterolactone increase stromaand cancer cellderived IL1Ra and decrease tumor angiogenesis in estrogendependent breast cancer［J］. Cancer Res, 2011, 71(1): 51-60. ［16］ Abrahamsson A, Morad V, Saarinen NM, et al. Estradiol, tamoxifen, and flaxseed alter IL1β and IL1Ra levels in normal human breast tissue in vivo［J］. J Clin Endocrinol Metab, 2012, 97(11): E2044-2054. ［17］ Aberg UW, Saarinen N, Abrahamsson A, et al. Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo［J］. PLoS One, 2011, 6(9): e25720. ［18］ Saarinen NM, Abrahamsson A, Dabrosin C. Estrogeninduced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo［J］. Int J Cancer, 2010, 127(3): 737-745. ［19］ Bendrik C, Dabrosin C. Estradiol increases IL8 secretion of normal human breast tissue and breast cancer in vivo［J］. J Immunol, 2009, 182(1): 371-378. ［20］ Leifler KS, Svensson S, Abrahamsson A, et al. Inflammation induced by MMP9 enhances tumor regression of experimental breast cancer［J］. J Immunol, 2013, 190(8): 4420-4430. ［21］ Hardt M, Lam DK, Dolan JC, et al. Surveying proteolytic processes in human cancer microenvironments by microdialysis and activitybased mass spectrometry［J］. Proteomics Clin Appl, 2011, 5(11-12): 636-643. ［22］ Wibom C, Surowiec I, Mrén L, et al. Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study［J］. J Proteome Res, 2010, 9(6): 2909-2919. ［23］ Tabatabaei P, Bergstrom P, Henriksson R, et al. Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy［J］. J Neurooncol, 2008, 90(1): 35-39. ［24］ Xu BJ, Yan W, Jovanovic B, et al. Microdialysis combined with proteomics for protein identification in breast tumor microenvironment in vivo［J］. Cancer Microenviron, 2010, 4(1): 61-71. ［25］ Rogers ML, Brennan PA, Leong CL, et al. Online rapid sampling microdialysis (rsMD) using enzymebased electroanalysis for dynamic detection of ischaemia during free flap reconstructive surgery［J］. Anal Bioanal Chem, 2013, 405(11): 38813888. ［26］ Ellebeak Pedersen M, Qvist N, Bisgaard C, et al. Peritoneal microdialysis.early diagnosis of anastomotic leakage after low anterior resection for rectosigmoid cancer［J］. Scand J Surg, 2009, 98(3): 148-154.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[3]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[4]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[5]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[6]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[7]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[8]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[9]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[10]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[11]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[12]	Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266.
[13]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[14]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[15]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments